Analysis Financial News

Colgate-Palmolive (India) Ltd. traded 1.95 per cent in Tuesday's trade at 01:13PM (IST). Around 6,381 shares changed hands on the counter. The scrip opened at Rs 2892.30 and touched an intraday high and low of Rs 2892.30 and Rs 2816.00, respectively, in the session so far. The stock of Colgate-Palmolive (India) Ltd. quoted a 52-week high of Rs 3893.00 and a 52-week low of Rs 2097.70.

Subscribe to enjoy similar stories. Stock markets like clean and crisp stories: This happened, so that happened. Like in early November, we were told that stock prices fell in October because foreign institutional investors (FIIs) sold Indian stocks worth ₹94,017 crore during the month.

Subscribe to enjoy similar stories. Patricia Greene had spent a month recovering from a devastating stroke when her Medicare Advantage insurer, a unit of UnitedHealth Group, decided to stop paying for her nursing home. The 85-year-old was so weak and fragile, her son said, that she couldn’t even get herself out of bed.

Aarti Industries while Goldman Sachs has a neutral rating on Britannia. Meanwhile, JP Morgan has overweight ratings on LIC and Hindalco.

The Nifty future closed positive with gains of 0.03% at 24226 levels on Monday. The volatility index India Vix fell by 1.38% to 14.27, indicating a decline in market volatility.

While stating that they are fully invested at all times with a bottom-up approach to investing in great businesses at attractive valuations, Trupti Agrawal, Fund Manager at WhiteOak Capital AMC, finds more opportunities within Private Financials, Consumer Discretionary, Industrials, Healthcare, and Communication Services. «Irrespective of market levels, at every point in time there will be companies which will be relatively undervalued and our portfolio will reflect some of these new ideas, if they meet our framework of great business,» she says. Edited excerpts from a chat: How have you been tweaking your portfolios in the last few months amid all the concern around valuation and earnings growth slowing down?

US policy landscape, though may be also reflected in valuations as markets have been anticipating the outcome,” says Gautam Chhaochharia — Head of Global Markets, India – UBS. In an interview with ETMarkets, Chhaochharia said: “IT Services sector may potentially benefit from US corporate tax cuts and thus higher spending, despite some worries around Visas” Edited excerpts:

TVS Motor Company with a target price of Rs 2,774. The current market price of TVS Motor is Rs 2,476.65. TVS Motor Company, incorporated in 1992, is a Large Cap company with a market cap of Rs 1,17,246.75 crore, operating in the Auto sector. TVS Motor's key products/revenue segments include Automobile — 2 & 3 Wheelers, Other Operating Revenue, Sale of services for the year ending 31-Mar-2024.

Sagility India will debut on the exchanges on Tuesday. Ahead of the listing, the company's shares were trading with a GMP of Rs 0.3 in the grey market. Considering the upper price band of Rs 30, the company's stock is expected to list at 1% at the bourses.

Donald Trump as U.S. president on expectations his administration will be crypto friendly. The world's biggest cryptocurrency has become one of the most eye-catching movers in the week since the election and touched $89,637 in Asia — a gain of more than 25% since Nov. 5.

Mayuresh Joshi, Head Equity, Marketsmith India, says the ratings for UPL probably look a little bit weak whereas their peers – Paradeep Phosphates and Sumitomo Chemical can do well. For Biocon to a certain extent, numbers are very patchy. One good quarter has been followed by two bad quarters and therefore the consistency in numbers delivery is still not coming through. At this juncture, Syngene remains as a better player on Marketsmith watch list compared to Biocon. Any first thoughts on UPL or any other specialty chemical name that you like? Mayuresh Joshi: No, I think numbers are a tad below par for UPL. The Advanta or the seeds business, has done relatively better, but they are seeing pricing headwinds specifically in the crop protection business. Now within the geographies that they probably operate out of, we are seeing some scenarios where there have been instances of floods in a few European countries as well and therefore how does this revenue build up specifically in the second half that they are maintaining their guidance and specifically on the EBITDA front is something to be watched out for.

With Q2 earnings season already turning out to be the worst since March 2020, Sunil Tirumalai, Chief GEM Equity Strategist at UBS, says chances of further earnings cuts are higher than earnings increases. «In the context of slowing signs in the economy (with nominal GDP growth currently in the bottom quartile of 15 year history), renewed fears of slowdown in global trade after changes in US political landscape, and a gradual slowdown in bank credit growth – it is hard to envisage a situation of sharp earnings increase for the stocks,» he says. Edited excerpts from a chat ahead of UBS India Summit:

Sampath Reddy, Founder & CIO, Azurean Investment Managers, says generally speaking the domestic institutions are a lot more bottom-up in terms of investing style and they do have a lot of exposure to the mid and smallcap segment. A continuous positive inflows into the domestic institutions is helping the valuations of mid and smallcap companies. That is why the mid and smallcaps are still relatively expensive. Reddy also says he would not be very optimistic about the way things will pan out when the new US president takes over. He will probably wait and see whether the order books or the new large orders are coming through for the IT services companies. We have seen an uptick in sentiment in IT stocks since the US election. Is it likely to convert into earnings as well? Sampath Reddy: At this moment, most of the analysts are of the opinion that with the expectation of the tax cuts by the new president, there is a possibility that corporates might spend more on the IT side, I think that is what is leading to that optimism. But with the way the commentary has been, I am not sure where the earnings have come for the Q2 numbers. The momentum is mostly waning away. The growth rates are below the expectations for Q2. At this juncture, I would not be very optimistic about the way things will pan out when the new president takes over.

IPO launch last week, the shares of food delivery company Swiggy will debut on the exchanges on Wednesday. Ahead of the listing, the company's shares are trading with a GMP of Rs 1 in the grey market, indicating a 0.26% premium over the issue price. The IPO, which was subscribed just over 3 times, was priced at Rs 390 at the upper end. The subscription response for the IPO was sluggish despite being the second-largest e-commerce and food delivery player.

NSE SME platform. Here are 10 key things investors need to know about the public offer before subscribing to the issue.

«Improved efficiency in collections over the next few quarters should positively impact asset quality, leading to reduced provisioning needs and boosting bottom-line growth, ROAs, and ROEs. Therefore, within the NBFC sector, microfinance is not advisable at this moment, but qualitative stocks like Chola are worth considering,» says Mayuresh Joshi, Head Equity, Marketsmith India. Suffice it to say, it's a big avoid for MFI right now? Mayuresh Joshi: Yes, and with regulatory concerns still looming, there is always a risk that potential regulatory actions could cast doubts on how these balance sheets might evolve, especially in terms of earnings if restrictions are imposed. Within this space, however, some housing finance companies have performed well. At Marketsmith, we focus on leading stocks, so within the broader NBFC universe, particularly from a rural discretionary spending perspective, Chola Investment and Finance could be a strong option. Our analysis suggests that Chola’s exposure, its strong parentage, and its capital adequacy, reflected in Tier I ratios, point to decreasing asset quality pressures as the rural economy strengthens. Improved efficiency in collections over the next few quarters should positively impact asset quality, leading to reduced provisioning needs and boosting bottom-line growth, ROAs, and ROEs. Therefore, within the NBFC sector, microfinance is not advisable at this moment, but qualitative stocks like Chola are worth considering.

Subscribe to enjoy similar stories. After a turbulent October marked by widespread selling across stock markets, some sectors are beginning to show signs of recovery, with the railway sector standing out. Despite a steep downturn in many railway stocks—some dropping over 20% from recent highs—the sector appears poised for a technical reversal, particularly in the short-term trend.

cryptocurrency, is expected to continue with investors betting on prices to cross $100,000 this year, riding the bullish momentum in the digital currency. It was trading above the $84,500 mark at press time.

Is buying Bitcoin and other cryptocurrencies legal in India? Yes. Investors can buy Bitcoin and other cryptocurrencies from government registered exchanges in India. However, it cannot be used as a currency and is only an investment product.

Akums Drugs and Pharmaceutical, the Delhi-based contract development and manufacturing organisation (CDMO) reported an adjusted net profit of Rs ₹66.7 crore, a 16% year-on-year (YoY) increase from the previous quarter led operational efficiency. Revenue declined 11.9% YoY to ₹1046.6 crore due to lower active pharmaceutical ingredient (API) prices and fluctuating demand.

Shree Cement’s profit plunged more than 80% on year to Rs 93.13 crore in the September quarter, weighed down by weakness in both demand and prices for the building material during the three-month period. While the September quarter is seasonally weak for cement-makers, the country’s third largest producer’s sales volume slipped as compared to the previous year as well — 7% lower at 7.60 million tonne.